LB773 Treating Pemphigus Vulgaris (PV) and Foliaceus (PF) by Inhibiting the Neonatal Fc Receptor: Phase 2 Multicentre Open-Label Trial with Efgartigimod
Journal of Investigative Dermatology(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined